Human FADD Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human FADD antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human FADD |
| Clone | polyclonal |
| Host Species | Mouse |
| Reactive Species | n/a |
| Isotype | n/a |
| Format | peroxidase (HRP) conjugate |
| Size | 1 mL |
| Concentration | n/a |
| Applications | ELISA (EIA), Immunoblot (IB), Immunoprecipitation (IP) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Human FADD. Fas-associated death domain (FADD, also known as MORT1) is an important apoptosis adapter molecule involved in the Fas-mediated cell death pathway. FADD associates with the intracellular domain of FAS (CD95/APO-1) through their respective C-terminal death domains (DD). The N-terminal region of FADD contains a death effectors domain (DED) which recruits and binds cytosolic proteins such as FLICE/caspase-8. The subsequent activation of FLICE by proteolytic cleavage leads to the activation of the caspase-mediated (ICE-related proteases) apoptotic cascade. Overexpression of FADD induces apoptosis which is inhibited by CrmA, a specific inhibitor of the interleukin-1beta-converting enzyme. FADD has also been shown under c |
| Immunogen | Immunogen: Recombinant FADD. Buffer Formulation: Supplied in a stock solution in 50% glycerol/50% PBS, pH 7.4; No preservative added |
| Other Names | [FAS-associated death domain protein; GIG3; MGC8528; MORT1], [FADD; FADD; GIG3; MORT1; MORT1] |
| Gene, Accession # | [FADD], Gene ID: 8772, NCBI: CAG33019.1, UniProt: Q13158 |
| Catalog # | MBS670616 |
| Price | $375 |
| Order / More Info | Human FADD Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies